Roche’s dual GLP-1/GIP receptor agonist has been tied to 22.5% weight loss at 48 weeks, validating the company’s decision to move the asset into phase 3 studies this quarter.

Lynsey Macfadyen used to turn to food for comfort, until weight-loss medication helped her reshape her relationship with food ...

Tirzepatide users on hormone therapy had added improvements in weight, cardiometabolic mar ...

New research reveals these medications impact everything from heart health to restaurant menus.

The new drugs could become the way forward for medicated weight loss as clinical trials reveal optimistic results ...

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement — What The Science Shows And What It Doesn'tMIAMI, FL, Jan. 09, 2026 ...

As the GLP-1 trend expands, a 'halo effect' is developing. Consumers in families of GLP-1 users are increasingly eating GLP-1 ...

University Hospitals cardiologist explains the benefits, side effects, and future of these increasingly popular drugs.

Oprah Winfrey got honest about her use of GLP-1 medications for weight loss, describing it as a trial-and-error journey.

With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...

Whoopi Goldberg issued a message appealing directly to Secretary of Health Robert F. Kennedy Jr. on The View after Oprah ...

The past year was one of turbulence and change at Novo Nordisk, and, while the Danish drugmaker still has its work cut out ...